Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Schjerning Olsen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Cardiology|October 1, 2013
Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarctionAnne-Marie Schjerning Olsen, Gunnar H Gislason, Emil L Fosbøl
Basic & Clinical Pharmacology & Toxicology|April 3, 2014
The impact of NSAID treatment on cardiovascular risk - insight from Danish observational dataAnne-Marie Schjerning Olsen, Emil L Fosbøl, Gunnar H Gislason
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2017
Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort studyCengiz Özcan, Anna Deleskog, Anne-Marie Schjerning Olsen, et al.
Ugeskrift for Laeger|January 3, 2017
[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment]Morten Schmidt, Emil Loldrup Fosbøl, Christian Torp-Pedersen, et al.
Plos One|June 13, 2015
Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and MortalityMette Nygaard Andersen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 24, 2012
Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safetyEmil L Fosbøl, Anne-Marie Schjerning Olsen, Jonas Bjerring Olesen, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort studyJesper Lindhardsen, Gunnar Hilmar Gislason, Søren Jacobsen, et al.
Basic & Clinical Pharmacology & Toxicology|November 29, 2018
Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritisCarlo Alberto Barcella, Morten Lamberts, Patricia McGettigan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2018
Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort StudyMette Nygaard Einfeldt, Anne-Marie Schjerning Olsen, Søren Lund Kristensen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart DiseaseMette Nygaard Andersen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Cardiology|October 1, 2013
Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarctionAnne-Marie Schjerning Olsen, Gunnar H Gislason, Emil L Fosbøl
Basic & Clinical Pharmacology & Toxicology|April 3, 2014
The impact of NSAID treatment on cardiovascular risk - insight from Danish observational dataAnne-Marie Schjerning Olsen, Emil L Fosbøl, Gunnar H Gislason
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2017
Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort studyCengiz Özcan, Anna Deleskog, Anne-Marie Schjerning Olsen, et al.
Ugeskrift for Laeger|January 3, 2017
[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment]Morten Schmidt, Emil Loldrup Fosbøl, Christian Torp-Pedersen, et al.
Plos One|June 13, 2015
Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and MortalityMette Nygaard Andersen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 24, 2012
Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safetyEmil L Fosbøl, Anne-Marie Schjerning Olsen, Jonas Bjerring Olesen, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort studyJesper Lindhardsen, Gunnar Hilmar Gislason, Søren Jacobsen, et al.
Basic & Clinical Pharmacology & Toxicology|November 29, 2018
Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritisCarlo Alberto Barcella, Morten Lamberts, Patricia McGettigan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2018
Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort StudyMette Nygaard Einfeldt, Anne-Marie Schjerning Olsen, Søren Lund Kristensen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart DiseaseMette Nygaard Andersen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, et al.
Pageof 3